3-fluoro-N-(4-{[2-(methylsulfonyl)pyrimidin-4-yl]oxy}-1-naphthyl)-5-morpholin-4-ylbenzamide → N-[4-({2-[[amino(imino)methyl](methyl)amino]pyrimidin-4-yl}oxy)-1-naphthyl]-3-fluoro-5-morpholin-4-ylbenzamide

Participants

Reaction Steps

Compound is prepared from 3-fluoro-N-(4-{[2-(methylsulfonyl)pyrimidin-4-yl]oxy}-1-naphthyl)-5-morpholin-4-ylbenzamide and N-methylguanidine according to conditions described in general procedure C. Mp: 155-157° C.; 1H NMR (400 MHz, DMSO-d6) δ 3.19-3.33(m, 7 H), 3.75-3.78(m, 4 H), 6.50(d, J=5.5 Hz, 1H), 7.04(d, J=12.0 Hz, 1 H), 7.27(d, J=9.1 Hz, 1 H), 7.34-7.68(m, 7 H), 7.80(d, J=8.8 Hz, 1H), 7.99(d, J=8.2 Hz, 1 H), 8.29(d, J=5.5 Hz, 1 H), 10.47(s, 1 H).

Provenance & Evidence